Scholarlink

<p>High serum uric acid (HUA) is linked to gout, fatty liver, and insulin resistance. Anti-hyperuricemic drugs were designed to lower uric acid production and/or inhibit urate reabsorption by renal and extra-renal tissues. While <i>Pandanus amaryllifolius</i> Roxb. ex Lindl. extract (PA) was reported to reduce uric acid production, the full effects of PA on urate metabolism were unclear. This study investigated PA impact on uric acid reabsorption and excretion in Wistar rats with potassium oxonate-induced HUA. Hyperuricemic rats showed elevated uric acid, reduced urinary excretion, decreased antioxidants, β-cell dysfunction, hyperglycemia, kidney damage, and hepatic fat. PA supplementation (0.5, 1, and 2&#xa0;g/kg) for 14 days lowered serum xanthine oxidase activity and uric acid levels, comparable to benzbromarone and less potently than allopurinol. This reduction was achieved by suppressing urate reabsorption and enhancing renal and intestinal urate excretion. Furthermore, PA alleviated β-cell dysfunction and hyperglycemia by improving insulin secretion and signaling (IRS1 and Akt activation). It also reduced hepatic lipid synthesis, stimulated lipolysis, and decreased hepatic fat accumulation and pro-inflammatory cytokines. These findings demonstrate PA xanthine oxidase inhibitory, uricosuric, antioxidant, and anti-inflammatory properties, highlighting its potential as a therapeutic agent for hyperuricemia and related hyperglycemia.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Uricosuric, antioxidant, and anti-inflammatory properties of Pandanus amaryllifolius Roxb. extract against potassium oxonate-induced hyperuricemia in rats

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月25日

查看全文
  • Panan Suntornsaratoon,
  • Wajathip Bulanawichit,
  • Sinee Siricoon,
  • Vitoon Saengsirisuwan,
  • Nattapon Panupinthu,
  • Nateetip Krishnamra,
  • Narattaphol Charoenphandhu

摘要

High serum uric acid (HUA) is linked to gout, fatty liver, and insulin resistance. Anti-hyperuricemic drugs were designed to lower uric acid production and/or inhibit urate reabsorption by renal and extra-renal tissues. While Pandanus amaryllifolius Roxb. ex Lindl. extract (PA) was reported to reduce uric acid production, the full effects of PA on urate metabolism were unclear. This study investigated PA impact on uric acid reabsorption and excretion in Wistar rats with potassium oxonate-induced HUA. Hyperuricemic rats showed elevated uric acid, reduced urinary excretion, decreased antioxidants, β-cell dysfunction, hyperglycemia, kidney damage, and hepatic fat. PA supplementation (0.5, 1, and 2 g/kg) for 14 days lowered serum xanthine oxidase activity and uric acid levels, comparable to benzbromarone and less potently than allopurinol. This reduction was achieved by suppressing urate reabsorption and enhancing renal and intestinal urate excretion. Furthermore, PA alleviated β-cell dysfunction and hyperglycemia by improving insulin secretion and signaling (IRS1 and Akt activation). It also reduced hepatic lipid synthesis, stimulated lipolysis, and decreased hepatic fat accumulation and pro-inflammatory cytokines. These findings demonstrate PA xanthine oxidase inhibitory, uricosuric, antioxidant, and anti-inflammatory properties, highlighting its potential as a therapeutic agent for hyperuricemia and related hyperglycemia.